Biodexa

Illustration work done for the client Biodexa Pharmaseuticals, showing the MOA of their MTX240 agent. Its unique molecular glue mechanism of action separates MTX240 from current standard of care with the potential to benefit a broad spectrum of GIST patients.

Made in collaboration with Life Science Animation.